Company profile: Eclipse Therapeutics
1.1 - Company Overview
Company description
- Provider of therapeutics discovery and development targeting cancer stem cells (CSCs) and other innovative cancer treatments.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Eclipse Therapeutics
Koya Medical
HQ: United States
Website
- Description: Provider of breakthrough treatments for lymphedema and venous diseases, as a transformative healthcare company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Koya Medical company profile →
LadRx
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics leveraging LADR (Linker Activated Drug Release) technology to bind anti-cancer molecules to albumin and release cytotoxic payloads at tumors, enabling higher doses with minimized off-target toxicity. Portfolio includes Aldoxorubicin, next-generation LADR-7, and Arimoclomol to amplify heat-shock proteins against protein misfolding, aggregation, and lysosomal dysfunction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LadRx company profile →
PDC Line Pharma
HQ: France
Website
- Description: Provider of clinical-stage active cancer immunotherapies based on an allogeneic plasmacytoid dendritic cell line (PDC*line) loaded with cancer antigens, including PDC*lung01, a therapeutic vaccine for non-small cell lung cancer used with anti-PD-1 to induce specific immune responses, and GeniusVac-Mel4, a vaccine designed to prime and expand antitumor T-cells in melanoma patients.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PDC Line Pharma company profile →
Tube Pharma
HQ: Austria
Website
- Description: Provider of biopharmaceutical research and development focused on cancer medicines, conducting pharmaceutical R&D for pancreatic, lung, and breast cancers, and collaborating with academic institutions and other biopharmaceutical companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tube Pharma company profile →
Myriad Genetics
HQ: United States
Website
- Description: Provider of genetic testing and molecular profiling solutions, including hereditary cancer risk assessment (MyRisk), pharmacogenomic testing for mental health medications (GeneSight), prostate cancer aggressiveness evaluation (Prolaris), tumor genomic profiling (Precise), carrier screening (Foresight), and non-invasive prenatal screening (Prequel).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Myriad Genetics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Eclipse Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Eclipse Therapeutics
2.2 - Growth funds investing in similar companies to Eclipse Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Eclipse Therapeutics
4.2 - Public trading comparable groups for Eclipse Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →